Immunotherapy has undoubtedly become an effective treatment for many cancers, but how can we make the most of this approach? In this Review, Meleroet al. discuss how immune-targeted therapies can be synergistically combined to provide maximal benefit to patients.
- Ignacio Melero
- David M. Berman
- John Haanen
